Latest News and Press Releases

Accelerates VLN® Launch with Key National Distribution AgreementsLaunching VLN® in Texas, California and Florida with New National Scale Distributor and Retail PartnersScaling Hemp/Cannabis Revenue...

Immediately Accretive Addition to the Hemp/Cannabis Business with Positive EBITDA 1,276 Novel Food Applications for Cannabinoid Products to Accelerate Growth in the U.K. and EU Food and...

BUFFALO, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...

Celebrates the Launch and Accelerated Expansion of VLN®, the Only Combustible Cigarettes Authorized by the FDA That “Helps You Smoke Less” VLN® 95% Less Nicotine Cigarette Pilot in Chicago Exceeded...

Further Enhances 22nd Century Group’s Deep Expertise in Plant-Based Biotechnology BUFFALO, N.Y., April 11, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural...

BUFFALO, N.Y., March 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), today announced that it has received notification from the Office of the Illinois Attorney General’s...

BUFFALO, N.Y., March 09, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...

Secured FDA MRTP Authorization for VLN® King and VLN® Menthol King Reduced Nicotine Content CigarettesAdvancing to U.S. Pilot Market Launch in ChicagoAnnounced Circle K as First VLN® Retail Trade...

BUFFALO, N.Y., Feb. 23, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...

BUFFALO, N.Y., Feb. 10, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...